Olopatadine Deaminated Impurity - Request Quote
Olopatadine Deaminated Impurity
| SZ CAT No: | SZ-O007037 |
| CAS No | NA |
| Mol.F. | C18H14O4 |
| Mol.Wt. | 294.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Olopatadine Deaminated Impurity is chemically (Z)-2-(11-(2-oxoethylidene)-6,11-dihydrodibenzo[b,e]oxepin-2-yl)acetic acid. Olopatadine Deaminated Impurity is supplied with detailed characterization data compliant with regulatory guideline. Olopatadine Deaminated Impurity can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Olopatadine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Olopatadine Deaminated Impurity
Purchase Olopatadine Deaminated Impurity
Olopatadine Deaminated Impurity suppliers
Olopatadine Deaminated Impurity manufacturers
Olopatadine Deaminated Impurity price
Order Olopatadine Deaminated Impurity
Enquire Olopatadine Deaminated Impurity
Olopatadine Deaminated Impurity cost
Olopatadine Deaminated Impurity Supplier
Olopatadine Deaminated Impurity Distributor
Olopatadine Deaminated Impurity for Method Validation
Olopatadine Reference Standard
Olopatadine Deaminated Impurity for ANDA Filing
Olopatadine Deaminated Impurity for Forced Degradation Studies
Olopatadine Deaminated Impurity Identification Standards
Olopatadine Deaminated Impurity for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


